WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of ($0.47), $0.06 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $1.24 million versus the consensus estimate of $7.06 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.